Strategies to optimize responses to seasonal influenza vaccination in older adults include
the use of adjuvants, higher antigen doses, and intradermal delivery. In this study adults …

The influenza vaccination is known as the most effective method for preventing influenza
infection and its complications in the elderly. Conventional subunit (Agrippal S1; Novartis) …

Background: MF59-adjuvanted influenza vaccines have superior immunogenicity in older
adults compared with non-adjuvanted vaccines. We assessed whether changing formulation …

Background The safety and immunogenicity of an MF59™-adjuvanted subunit influenza
vaccine (Sub/MF59™; FLUAD®, Novartis Vaccines) was evaluated among elderly Chinese …

BACKGROUND: Adding adjuvants such as MF59® to influenza vaccines can enhance the
immune response. This analysis evaluated the safety profile of MF59-adjuvanted [(+) MF59] …

We conducted a randomized, controlled, multicenter, phase II study to evaluate the
immunogenicity and safety of an investigational intradermal (ID) trivalent influenza vaccine …

Aim Adjuvanted influenza vaccines can overcome the poor antibody response of
conventional non-adjuvanted vaccines in the elderly. We evaluated the immunogenicity …

Because of the age-related immune system decline, 2 potentiated influenza vaccines were
specifically licensed for the elderly: Fluad®, an MF59-adjuvanted vaccine administered …

The adjuvanted influenza vaccine FLUAD™ is composed of subunit influenza antigens
combined with the MF59-adjuvant emulsion. The vaccine was developed primarily for use in …

Influenza is a highly contagious respiratory disease associated with substantial morbidity
and mortality in vulnerable populations, especially the elderly. Influenza viruses are unique …